Greg Caldwell
Greg Caldwell's work spans corporate, portfolio, and pipeline strategy, operational excellence, M&A and asset monetization, new product planning and launch, and enterprise AI strategy and implementation, covering the full arc of value creation across the biopharma enterprise.
He has led pipeline prioritization and governance engagements, supported multi-billion dollar transactions, designed and deployed AI capabilities across R&D and commercial functions, and built the integrated launch and operational frameworks that translate strategy into measurable patient and business outcomes.
Across each domain, his focus remains constant: equipping leadership teams with the strategic clarity, operational rigor, and capability infrastructure required to move faster and more decisively at the moments that matter most.
